LT4 monotherapy remains the standard treatment for hypothyroidism, although a subset of patients continues to have ...

A new combination therapy is showing promise in reducing facial redness caused by rosacea, a common skin condition.

Application error: a client-side exception has occurred (see the browser console for more information).

The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and Cellular Oncogenesis Program, and colleagues have discovered a new approach to ...

The differentiated clinical value of the penpulimab combination therapy is expected to offer a more effective solution for patients with liver cancer. The sNDA for this new indication is supported ...

Wistar Institute scientists have discovered a new approach to treating ovarian cancer that, in preclinical laboratory testing, shrinks tumors and improves survival rates while simultaneously making ...

The observed changes were favorable, but results may have been affected by better-than-normal care in the control arm.

Breztri Aerosphere® is a long-term medicine to treat COPD and give patients better breathing, improve COPD symptoms and ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...